Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK

Anesthesia and Analgesia

Volumn 101, Issue 6, 2005, Pages 1584-1589

  Hashiguchi, Hideo ^a   Morooka, Hiroaki ^a   Miyoshi, Hiroshi ^a   Matsumoto, Masanori ^a   Koji, Takehiko ^a   Sumikawa, Koji ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ISOFLURANE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; SIGNAL TRANSDUCTION; UREA NITROGEN BLOOD LEVEL;

EID: 28344437669     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000184044.51749.B8     Document Type: Article

References (25)

1. Star RA. Treatment of acute renal failure. Kidney Int 1998;54: 1817-31.
2. Tsuchida A, Miura T, Tanno M, et al. Infarct size limitation by nicorandil: roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C. J Am Coll Cardiol 2002;40:1523-30.
3. Kersten JR, Schmeling TJ, Hettrick DA, et al. Mechanism of myocardial protection by isoflurane: role of adenosine triphosphate-regulated potassium (KATP) channels. Anesthesiology 1996;85:794-807.
4. Sullivan BL, Leu D, Taylor DM, et al. Isoflurane prevents delayed cell death in an organotypic slice culture model of cerebral ischemia. Anesthesiology 2002;96:189-95.
5. 3 receptors. Am J Physiol Renal Physiol 2000;278:F380-7.
6. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14:2199-210.
7. Ishii M, Suzuki Y, Takeshita K, et al. Inhibition of c-jun NH(2)-terminal kinase activity improves ischemia/reperfusion injury in rat lungs. J Immunol 2004;15:2569-77.
8. Kharbanda RK, Peters M, Walton B, et al. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia/reperfusion in humans in vivo. Circulation 2001;103:1624-30.
9. de klaver MJ, Manning L, Palmer LA, Rich GF. Isoflurane pretreatment inhibits cytokine-induced cell death in cultured rat smooth muscle cells and human endothelial cells. Anesthesiology 2002;97:24-32.
10. Liu R, Ishibe Y, Ueda M. Isoflurane-sevoflurane administration before ischemia attenuates ischemia-reperfusion-induced injury in isolated rat lungs. Anesthesiology 2000;92:833-40.
11. Glanemann M, Strenziok R, Kuntze R, et al. Ischemic preconditioning and methylprednisolone both equally reduce hepatic ischemia/reperfusion injury. Surgery 2004;135:203-14.
12. Ferrandi C, Ballerio R, Gaillard P, et al. Inhibition of c-jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats. Br J Pharmacol 2004;142:953-60.
13. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002;298:1911-2.
14. Pombo CM, Bonventre JV, Avruch J, et al. The stress-activated protein kinases are major c-jun amino-terminal kinases activated by ischemia and reperfusion. J Biol Chem 1994;269: 26546-51.
15. Morooka H, Bonventre JV, Pombo CM, et al. Ischemia and reperfusion enhance ATF-2 and to an AP-I binding site from the c-jun promoter. J Biol Chem 1995;270:30084-92.
16. Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/reperfusion- induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 2001;276:11870-6.
17. Kochansky CJ, Koziol S, Strein TG. Electrophoretically mediated microanalysis with small molecules: the Jaffe method for creatinine carried out in a capillary tube. Electrophoresis 2001;22: 2518-25.
18. Khan FA, Dilawar M, Khan DA. Reference values of common blood chemistry analytes in healthy population of Rawalpindi-Islamabad area. J Pak Med Assoc 1997;47:156-9.
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
20. Jablonski P, Howden BO, Rae DA, et al. An experimental model for assessment of renal recovery from warm ischemia. Transplantation 1983;35:198-204.
21. Conzen PF, Vollamar B, Habazettl H, et al. Systemic and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg 1992;74:79-88.
22. Yin T, Sandhu G, Wolfgang CD, et al. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem 1997;272:19943-50.
23. Srivastava S, weitzmann MN, Cenci SR, et al. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest 1999;104: 503-13.
24. Lee HS, Kim HJ, Moon CS, et al. Inhibition of c-Jun NH2-terminal kinase or extracellular signal-regulated kinase improves lung injury. Respir Res 2004;5:23-38.
25. Yue TL, Wang C, Gu JL, et al. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 2000; 86:692-9.